Copyright
©The Author(s) 2021.
World J Transplant. Nov 18, 2021; 11(11): 443-465
Published online Nov 18, 2021. doi: 10.5500/wjt.v11.i11.443
Published online Nov 18, 2021. doi: 10.5500/wjt.v11.i11.443
Figure 1 Advantages and disadvantages of glucocorticoids in solid organ transplantation.
CNI: Calcineurin inhibitor; GC: Glucocorticoid; GVHD: Graft vs host disease; IRI: Ischemia-reperfusion injury; PTLD: Post-transplant lymphoproliferative disorder; SOT: Solid organ transplantation.
- Citation: Dashti-Khavidaki S, Saidi R, Lu H. Current status of glucocorticoid usage in solid organ transplantation. World J Transplant 2021; 11(11): 443-465
- URL: https://www.wjgnet.com/2220-3230/full/v11/i11/443.htm
- DOI: https://dx.doi.org/10.5500/wjt.v11.i11.443